GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » RushNet Inc (OTCPK:RSHN) » Definitions » Capex-to-Revenue

RushNet (RushNet) Capex-to-Revenue : 0.00 (As of . 20)


View and export this data going back to . Start your Free Trial

What is RushNet Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

RushNet's Capital Expenditure for the three months ended in . 20 was $0.00 Mil. Its Revenue for the three months ended in . 20 was $0.00 Mil.

GuruFocus do not calculate Capex-to-Revenue if the revenue is negative.

RushNet Capex-to-Revenue Historical Data

The historical data trend for RushNet's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RushNet Capex-to-Revenue Chart

RushNet Annual Data
Trend
Capex-to-Revenue

RushNet Quarterly Data
Capex-to-Revenue

Competitive Comparison of RushNet's Capex-to-Revenue

For the Diagnostics & Research subindustry, RushNet's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

RushNet's Capex-to-Revenue Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, RushNet's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where RushNet's Capex-to-Revenue falls into.


RushNet Capex-to-Revenue Calculation

RushNet's Capex-to-Revenue for the fiscal year that ended in . 20 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- () /
=N/A

RushNet's Capex-to-Revenue for the quarter that ended in . 20 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- () /
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

RushNet  (OTCPK:RSHN) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.

RushNet Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of RushNet's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

RushNet (RushNet) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » RushNet Inc (OTCPK:RSHN) » Definitions » Capex-to-Revenue
Comparable Companies
MOJO LBIX KRED FTFT CRVP JSDA TRUU WTER REED LTEA BRFH NBEV CELH PRMW DYDIF OCVLF LSDAF RFFRY COT COKE
Traded in Other Exchanges
N/A
Address
8465 Merchants Way, Suite 206, Orange Park, FL, USA, 32222
Website
https://www.rushnetinc.com
RushNet Inc through its subsidiary heliosDX, a National Clinical Reference Laboratory offers High-Complexity Urine Drug Testing (UDT), Behavioral Drug Testing, Allergy Droplet Cards, Oral Fluids, Infectious Disease (PCR), and NGS Genetic Testing. The firm provides physicians individualized customer service, as well as fast and accurate reporting of results. The company invests in its infrastructure with the most efficient scientific proven instruments, and latest software for patient and physician satisfaction. It allows heliosDX to provide physicians fast and accurate reporting meeting. The firm excels in patient and client care through physician designed panels that aid in testing compliance and reporting education.